Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002478:Cells, Cultured; D004048:Diethylamines / Q000627:therapeutic use; D005449:Fluorenes / Q000627:therapeutic use*; D007369:Interferon Inducers / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011714:Pyrans / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004048:Diethylamines; D005449:Fluorenes; D007369:Interferon Inducers; D011714:Pyrans